Detalles de la búsqueda
1.
Suppression of human and simian immunodeficiency virus replication with the CCR5-specific antibody Leronlimab in two species.
PLoS Pathog
; 18(3): e1010396, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35358290
2.
Safety and efficacy of vebicorvir in virologically suppressed patients with chronic hepatitis B virus infection.
J Hepatol
; 77(3): 642-652, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35460726
3.
Safety and efficacy of vebicorvir administered with entecavir in treatment-naïve patients with chronic hepatitis B virus infection.
J Hepatol
; 77(5): 1265-1275, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35697332
4.
All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III study.
Hepatology
; 61(4): 1127-35, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25614962
5.
On-treatment HCV RNA as a predictor of sustained virological response in HCV genotype 3-infected patients treated with daclatasvir and sofosbuvir.
Liver Int
; 36(11): 1611-1618, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27188960
6.
Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in HIV-Infected Adults Previously Vaccinated With Pneumococcal Polysaccharide Vaccine.
J Infect Dis
; 212(1): 18-27, 2015 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25395187
7.
Bictegravir/emtricitabine/tenofovir alafenamide plus doravirine in highly treatment-experienced men with multidrug-resistant HIV.
AIDS
; 37(7): 1057-1064, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36927740
8.
Anti-HIV-1 activity of weekly or biweekly treatment with subcutaneous PRO 140, a CCR5 monoclonal antibody.
J Infect Dis
; 201(10): 1481-7, 2010 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20377413
9.
Case study of a critically ill person with COVID-19 on ECMO successfully treated with leronlimab.
J Transl Autoimmun
; 4: 100097, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33778462
10.
Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab.
J Transl Autoimmun
; 4: 100083, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33521616
11.
Phase 2a study of the CCR5 monoclonal antibody PRO 140 administered intravenously to HIV-infected adults.
Antimicrob Agents Chemother
; 54(10): 4137-42, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20660677
12.
Safety and efficacy of the HIV-1 attachment inhibitor prodrug fostemsavir in heavily treatment-experienced individuals: week 96 results of the phase 3 BRIGHTE study.
Lancet HIV
; 7(11): e740-e751, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33128903
13.
Safety, tolerability, pharmacokinetics, and efficacy of an interleukin-2 agonist among HIV-infected patients receiving highly active antiretroviral therapy.
J Interferon Cytokine Res
; 28(2): 89-100, 2008 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18279104
14.
Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America.
N Engl J Med
; 348(22): 2175-85, 2003 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-12637625
15.
TORO: ninety-six-week virologic and immunologic response and safety evaluation of enfuvirtide with an optimized background of antiretrovirals.
AIDS Patient Care STDS
; 21(8): 533-43, 2007 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-17711378
16.
Safety and efficacy of the HIV-1 attachment inhibitor prodrug fostemsavir in antiretroviral-experienced subjects: week 48 analysis of AI438011, a Phase IIb, randomized controlled trial.
Antivir Ther
; 22(3): 215-223, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-27922453
17.
Enfuvirtide for nurses: answering patient questions on activity, safety, and lifestyle impact.
J Assoc Nurses AIDS Care
; 16(5): 26-34, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-16433107
18.
Safety and efficacy of the HIV-1 attachment inhibitor prodrug BMS-663068 in treatment-experienced individuals: 24 week results of AI438011, a phase 2b, randomised controlled trial.
Lancet HIV
; 2(10): e427-37, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26423650
19.
A phase II clinical study of the long-term safety and antiviral activity of enfuvirtide-based antiretroviral therapy.
AIDS
; 17(5): 691-8, 2003 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-12646792
20.
Assessment of drug-drug interaction potential of enfuvirtide in human immunodeficiency virus type 1-infected patients.
Clin Pharmacol Ther
; 75(6): 558-68, 2004 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-15179410